Stay updated with breaking news from Multiple Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reports new positive interim data from the ongoing Phase 1 study of BHV-1300, Biohaven's lead investigational drug from its Molecular Degrader of Extracellular...
From May 30 to June 2, participating cafes will display QR codes that link to informative resources and personal stories of people living with the condition
Scientists have published a new framework to help guide research that seeks to understand how exercise benefits people with MS.
A bench dedication ceremony took place for one of the original members of Woodstock's Accessibility Advisory Committee.
Benchmark restated their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 price objective on shares of Clene in a research note on Wednesday, […]